Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Anavex Life Sciences Corp. - Common Stock (NQ:AVXL)

1.920 -0.100 (-4.95%)
Delayed Quote Updated: 2:18 PM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,498,549
Open 2.000
Bid (Size) 1.920 (2,000)
Ask (Size) 1.930 (3,000)
Prev. Close 2.020
Today's Range 1.880 - 2.010
52wk Range 1.890 - 10.38
Shares Outstanding 89,348,107
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Law Offices of Frank R. Cruz Encourages Anavex Life Sciences Corp. (AVXL) Shareholders To Inquire About Securities Fraud Class Action
From Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Securities Fraud Investigation Into Anavex Life Sciences Corp. (AVXL) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire

Performance

YTD
-47.8%
-47.8%
1 Month
-31.4%
-31.4%
3 Month
-25.6%
-25.6%
6 Month
-38.1%
-38.1%
1 Year
-78.4%
-78.4%

More News

Read More
News headline image
Anavex Life Sciences Corp. (AVXL) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
ANAVEX LIFE SCIENCES CORP (NASDAQ:AVXL) Reports Q1 2026 Earnings Beat, Stock Gains in Pre-Market ↗
Via Chartmill
Topics Earnings
News headline image
Securities Class Action Filed Against Anavex Life Sciences Corp. – AVXL Investors Encouraged to Contact Kirby McInerney LLP
From Kirby McInerney LLP
Via Business Wire
News headline image
Securities Fraud Investigation Into Anavex Life Sciences Corp. (AVXL) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Anavex Life Sciences Corp. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – AVXL
From The DJS Law Group
Via Business Wire
News headline image
AVXL INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Anavex Life Sciences Corp. Investors – Holzer & Holzer, LLC Encourages Investors With Losses to Contact the Firm
From Holzer & Holzer
Via GlobeNewswire
News headline image
AVXL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Anavex (NASDAQ: AVXL) Investors of Securities Class Action Lawsuit Deadline on November 30, 2026
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
Stockholder Alert: Robbins LLP Informs Investors of the Anavex Life Sciences Corp. Class Action Lawsuit
From Robbins LLP
Via Business Wire
News headline image
AVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit with SBS Law
From Schall, Brown & Schwartz LLP
Via Business Wire
News headline image
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Anavex Life Sciences Corp. Investors – AVXL
From Rosen Law Firm
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL
From Pomerantz LLP
Via GlobeNewswire
News headline image
Rosen Law Firm Encourages Anavex Life Sciences Corp. Investors to Inquire About Securities Class Action Investigation
From The Rosen Law Firm, P.A.
Via Business Wire
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Wednesday's session: top gainers and losers ↗
Via Chartmill
Which stocks are gapping on Wednesday? ↗
Via Chartmill
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
News headline image
Anavex (AVXL) Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
These stocks are moving in today's after hours session ↗
Via Chartmill
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Anavex Life Sciences Corp. – AVXL
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL
From Pomerantz LLP
Via GlobeNewswire
News headline image
AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm
From Schall Law
Via GlobeNewswire

Frequently Asked Questions

Is Anavex Life Sciences Corp. - Common Stock publicly traded?
Yes, Anavex Life Sciences Corp. - Common Stock is publicly traded.
What exchange does Anavex Life Sciences Corp. - Common Stock trade on?
Anavex Life Sciences Corp. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Anavex Life Sciences Corp. - Common Stock?
The ticker symbol for Anavex Life Sciences Corp. - Common Stock is AVXL on the Nasdaq Stock Market
What is the current price of Anavex Life Sciences Corp. - Common Stock?
The current price of Anavex Life Sciences Corp. - Common Stock is 1.920
When was Anavex Life Sciences Corp. - Common Stock last traded?
The last trade of Anavex Life Sciences Corp. - Common Stock was at 10/01/26 02:18 PM ET
What is the market capitalization of Anavex Life Sciences Corp. - Common Stock?
The market capitalization of Anavex Life Sciences Corp. - Common Stock is 171.55M
How many shares of Anavex Life Sciences Corp. - Common Stock are outstanding?
Anavex Life Sciences Corp. - Common Stock has 172M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.